VIIBRYD (Avera McKennan Hospital)


Welcome to the PulseAid listing for the VIIBRYD drug offered from Avera McKennan Hospital. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: vilazodone hydrochloride
SUBSTANCE NAME: VILAZODONE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-03-03
END MARKETING DATE: 0000-00-00


VIIBRYD HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVIIBRYD from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2015-03-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-1110_d3bd1cc3-9dfe-49aa-8894-c7d4bcef8171
PRODUCT NDC: 69189-1110
APPLICATION NUMBER: NDA022567

Other VILAZODONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.VIIBRYD
Avera McKennan HospitalVIIBRYD
Cardinal HealthVIIBRYD